Relationships between computer-extracted mammographic texture pattern features and BRCA1/2 mutation status: A cross-sectional study

Breast Cancer Research

Volumn 16, Issue 4, 2014, Pages

  Gierach, Gretchen L ^a   Li, Hui ^b   Loud, Jennifer T ^a   Greene, Mark H ^a   Chow, Catherine K ^c   Lan, Li ^b   Prindiville, Sheila A ^a   Eng Wong, Jennifer ^d   Soballe, Peter W ^e   Giambartolomei, Claudia ^f   Mai, Phuong L ^a   Galbo, Claudia E ^g,h   Nichols, Kathryn ⁱ   Calzone, Kathleen A ^a   Olopade, Olufunmilayo I ^b   Gail, Mitchell H ^a   Giger, Maryellen L ^b  

^a NATIONAL CANCER INSTITUTE   (United States)

^b UNIVERSITY OF CHICAGO   (United States)

^c Washington Radiology Associates   (United States)

^d GENENTECH INC   (United States)

^e Uniformed Services University of the Health Sciences and the Walter Reed National Military Medical Center   (United States)

^f UNIVERSITY COLLEGE LONDON   (United Kingdom)

^g UNIFORMED SERVICES UNIVERSITY OF THE HEALTH SCIENCES   (United States)

^h WALTER REED ARMY MEDICAL CENTER   (United States)

ⁱ WESTAT   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BRCA1 PROTEIN; BRCA2 PROTEIN;

ADULT; ARTICLE; ARTIFICIAL NEURAL NETWORK; AUTOMATION; BODY MASS; BREAST DENSITY; CROSS-SECTIONAL STUDY; FEMALE; GENE MUTATION; HIGH RISK POPULATION; HUMAN; MAJOR CLINICAL STUDY; MAMMOGRAPHY; RADIOGRAPHY; SENSITIVITY ANALYSIS; ABNORMALITIES; AGED; BREAST NEOPLASMS; GENETICS; HETEROZYGOTE; INFORMATION PROCESSING; MAMMARY GLAND; MIDDLE AGED; MUTATION; PATHOLOGY; RISK FACTOR; SENSITIVITY AND SPECIFICITY; TUMOR SUPPRESSOR GENE;

ADULT; AGED; BREAST NEOPLASMS; DATASETS AS TOPIC; FEMALE; GENES, BRCA1; GENES, BRCA2; HETEROZYGOTE; HUMANS; MAMMARY GLANDS, HUMAN; MAMMOGRAPHY; MIDDLE AGED; MUTATION; RISK FACTORS; SENSITIVITY AND SPECIFICITY;

EID: 84910051472     PISSN: 14655411     EISSN: 1465542X     Source Type: Journal    
DOI: 10.1186/s13058-014-0424-8     Document Type: Article

References (58)

1. Boyd NF, Lockwood GA, Byng JW, Tritchler DL, Yaffe MJ. Mammographic densities and breast cancer risk. Cancer Epidemiol Biomarkers Prev 1998, 7:1133-1144. 9865433.
2. Haars G, van Noord PA, van Gils CH, Peeters PH, Grobbee DE. Heritable aspects of dysplastic breast glandular tissue (DY). Breast Cancer Res Treat 2004, 87:149-156. 10.1023/B:BREA.0000041621.48575.9b, 15377839.
3. Kaprio J, Alanko A, Kivisaari L, Standertskjold-Nordenstam CG. Mammographic patterns in twin pairs discordant for breast cancer. Br J Radiol 1987, 60:459-462. 10.1259/0007-1285-60-713-459, 3580756.
4. Kataoka M, Antoniou A, Warren R, Leyland J, Brown J, Audley T, Easton D. Genetic models for the familial aggregation of mammographic breast density. Cancer Epidemiol Biomarkers Prev 2009, 18:1277-1284. 10.1158/1055-9965.EPI-08-0568, 19336563.
5. Pankow JS, Vachon CM, Kuni CC, King RA, Arnett DK, Grabrick DM, Rich SS, Anderson VE, Sellers TA. Genetic analysis of mammographic breast density in adult women: evidence of a gene effect. J Natl Cancer Inst 1997, 89:549-556. 10.1093/jnci/89.8.549, 9106643.
6. Vachon CM, King RA, Atwood LD, Kuni CC, Sellers TA. Preliminary sibpair linkage analysis of percent mammographic density. J Natl Cancer Inst 1999, 91:1778-1779. 10.1093/jnci/91.20.1778, 10528030.
7. Vachon CM, Sellers TA, Carlson EE, Cunningham JM, Hilker CA, Smalley RL, Schaid DJ, Kelemen LE, Couch FJ, Pankratz VS. Strong evidence of a genetic determinant for mammographic density, a major risk factor for breast cancer. Cancer Res 2007, 67:8412-8418. 10.1158/0008-5472.CAN-07-1076, 17804758.
8. Wolfe JN, Albert S, Belle S, Salane M. Familial influences on breast parenchymal patterns. Cancer 1980, 46:2433-2437. 10.1002/1097-0142(19801201)46:11<2433::AID-CNCR2820461123>3.0.CO;2-E, 7438019.
9. Boyd N, Dite G, Stone J, Gunasekara A, English D, McCredie M. Heritability of mammographic density, a risk factor for breast cancer. N Engl J Med 2002, 19:886-894. 10.1056/NEJMoa013390.
10. Ursin G, Lillie EO, Lee E, Cockburn M, Schork NJ, Cozen W, Parisky YR, Hamilton AS, Astrahan MA, Mack T. The relative importance of genetics and environment on mammographic density. Cancer Epidemiol Biomarkers Prev 2009, 18:102-112. 10.1158/1055-9965.EPI-07-2857, 19124487.
11. Passaperuma K, Warner E, Hill KA, Gunasekara A, Yaffe MJ. Is mammographic breast density a breast cancer risk factor in women with BRCA mutations?. J Clin Oncol 2010, 28:3779-3783. 10.1200/JCO.2009.27.5933, 20625126.
12. Mitchell G, Antoniou AC, Warren R, Peock S, Brown J, Davies R, Mattison J, Cook M, Warsi I, Evans DG, Eccles D, Douglas F, Paterson J, Hodgson S, Izatt L, Cole T, Burgess L, Eeles R, Easton DF. Mammographic density and breast cancer risk in BRCA1 and BRCA2 mutation carriers. Cancer Res 2006, 66:1866-1872. 10.1158/0008-5472.CAN-05-3368, 16452249.
13. Clark AS, Domchek SM. Clinical management of hereditary breast cancer syndromes. J Mammary Gland Biol Neoplasia 2011, 16:17-25. 10.1007/s10911-011-9200-x, 21360002.
14. Gierach GL, Loud JT, Chow CK, Prindiville SA, Eng-Wong J, Soballe PW, Giambartolomei C, Mai PL, Galbo CE, Nichols K, Calzone KA, Vachon C, Gail MH, Greene MH. Mammographic density does not differ between unaffected BRCA1/2 mutation carriers and women at low-to-average risk of breast cancer. Breast Cancer Res Treat 2010, 123:245-255. 10.1007/s10549-010-0749-7, 20130984.
15. Helvie MA, Roubidoux MA, Weber BL, Merajver SD. Mammography of breast carcinoma in women who have mutations of the breast cancer gene BRCA1: initial experience. Am J Roentgenol 1997, 168:1599-1602. 10.2214/ajr.168.6.9168735.
16. Tilanus-Linthorst M, Verhoog L, Obdeijn IM, Bartels K, Menke-Pluymers M, Eggermont A, Klijn J, Meijers-Heijboer H, van der Kwast T, Brekelmans C. A BRCA1/2 mutation, high breast density and prominent pushing margins of a tumor independently contribute to a frequent false-negative mammography. Int J Cancer 2002, 102:91-95. 10.1002/ijc.10666, 12353239.
17. Hamilton LJ, Evans AJ, Wilson AR, Scott N, Cornford EJ, Pinder SE, Khan HN, Macmillan RD. Breast imaging findings in women with BRCA1- and BRCA2-associated breast carcinoma. Clin Radiol 2004, 59:895-902. 10.1016/j.crad.2004.03.013, 15451348.
18. Kaas R, Kroger R, Peterse JL, Hart AA, Muller SH. The correlation of mammographic-and histologic patterns of breast cancers in BRCA1 gene mutation carriers, compared to age-matched sporadic controls. Eur Radiol 2006, 16:2842-2848. 10.1007/s00330-006-0385-0, 16924440.
19. Huo Z, Giger ML, Olopade OI, Wolverton DE, Weber BL, Metz CE, Zhong W, Cummings SA. Computerized analysis of digitized mammograms of BRCA1 and BRCA2 gene mutation carriers. Radiology 2002, 225:519-526. 10.1148/radiol.2252010845, 12409590.
20. Li H, Giger ML, Huo Z, Olopade OI, Lan L, Weber BL, Bonta I. Computerized analysis of mammographic parenchymal patterns for assessing breast cancer risk: effect of ROI size and location. Med Phys 2004, 31:549-555. 10.1118/1.1644514, 15070253.
21. Yaffe M. Mammographic density: measurement of mammographic density. Breast Cancer Res 2008, 10:209. 10.1186/bcr2102, 18598375.
22. Byng JW, Yaffe MJ, Lockwood GA, Little LE, Tritchler DL, Boyd NF. Automated analysis of mammographic densities and breast carcinoma risk. Cancer 1997, 80:66-74. 10.1002/(SICI)1097-0142(19970701)80:1<66::AID-CNCR9>3.0.CO;2-D, 9210710.
23. Haberle L, Wagner F, Fasching PA, Jud SM, Heusinger K, Loehberg CR, Hein A, Bayer CM, Hack CC, Lux MP, Binder K, Elter M, Munzenmayer C, Schulz-Wendtland R, Meier-Meitinger M, Adamietz BR, Uder M, Beckmann MW, Wittenberg T. Characterizing mammographic images by using generic texture features. Breast Cancer Res 2012, 14:R59. 10.1186/bcr3163, 22490545.
24. Manduca A, Carston MJ, Heine JJ, Scott CG, Pankratz VS, Brandt KR, Sellers TA, Vachon CM, Cerhan JR. Texture features from mammographic images and risk of breast cancer. Cancer Epidemiol Biomarkers Prev 2009, 18:837-845. 10.1158/1055-9965.EPI-08-0631, 19258482.
25. Nielsen M, Karemore G, Loog M, Raundahl J, Karssemeijer N, Otten JDM, Karsdal MA, Vachon CM, Christiansen C. A novel and automatic mammographic texture resemblance marker is an independent risk factor for breast cancer. Cancer Epidemiol 2011, 35:381-387. 10.1016/j.canep.2010.10.011, 21146484.
26. Wei J, Chan H-P, Wu Y-T, Zhou C, Helvie MA, Tsodikov A, Hadjiiski LM, Sahiner B. Association of computerized mammographic parenchymal pattern measure with breast cancer risk: a pilot case-control study. Radiology 2011, 260:42-49. 10.1148/radiol.11101266, 21406634.
27. Li H, Giger ML, Olopade OI, Chinander MR. Power spectral analysis of mammographic parenchymal patterns for breast cancer risk assessment. J Digit Imaging 2008, 21:145-152. 10.1007/s10278-007-9093-9, 18175183.
28. Li H, Giger ML, Olopade OI, Lan L. Fractal analysis of mammographic parenchymal patterns in breast cancer risk assessment. Acad Radiol 2007, 14:513-521. 10.1016/j.acra.2007.02.003, 17434064.
29. Li H, Giger ML, Olopade OI, Margolis A, Lan L, Chinander MR. Computerized texture analysis of mammographic parenchymal patterns of digitized mammograms. Acad Radiol 2005, 12:863-873. 10.1016/j.acra.2005.03.069, 16039540.
30. Huo Z, Giger ML, Wolverton DE, Zhong W, Cumming S, Olopade OI. Computerized analysis of mammographic parenchymal patterns for breast cancer risk assessment: feature selection. Med Phys 2000, 27:4-12. 10.1118/1.598851, 10659732.
31. Yaffe MJ, Boyd NF, Byng JW, Jong RA, Fishell E, Lockwood GA, Little LE, Tritchler DL. Breast cancer risk and measured mammographic density. Eur J Cancer Prev 1998, 7:S47-S55. 10.1097/00008469-199802001-00010, 10866036.
32. Torres-Mejia G, De Stavola B, Allen DS, Perez-Gavilan JJ, Ferreira JM, Fentiman IS, Dos Santos Silva I. Mammographic features and subsequent risk of breast cancer: a comparison of qualitative and quantitative evaluations in the Guernsey prospective studies. Cancer Epidemiol Biomarkers Prev 2005, 14:1052-1059. 10.1158/1055-9965.EPI-04-0717, 15894652.
33. Loud JT, Beckjord EB, Nichols K, Peters J, Giusti R, Greene MH. Tolerability of breast ductal lavage in women from families at high genetic risk of breast cancer. BMC Womens Health 2009, 9:20. 10.1186/1472-6874-9-20, 19602282.
34. Loud JT, Thiebaut AC, Abati AD, Filie AC, Nichols K, Danforth D, Giusti R, Prindiville SA, Greene MH. Ductal lavage in women from BRCA1/2 families: is there a future for ductal lavage in women at increased genetic risk of breast cancer?. Cancer Epidemiol Biomarkers Prev 2009, 18:1243-1251. 10.1158/1055-9965.EPI-08-0795, 19336560.
35. Gail MH, Brinton LA, Byar DP, Corle DK, Green SB, Schairer C, Mulvihill JJ. Projecting individualized probabilities of developing breast cancer for white females who are being examined annually. J Natl Cancer Inst 1989, 81:1879-1886. 10.1093/jnci/81.24.1879, 2593165.
36. Hoskins KF, Zwaagstra A, Ranz M. Validation of a tool for identifying women at high risk for hereditary breast cancer in population-based screening. Cancer 2006, 107:1769-1776. 10.1002/cncr.22202, 16967460.
37. Nelson HD, Fu R, Goddard K, Mitchell JP, Okinaka-Hu L, Pappas M, Zakher B. Risk Assessment, Genetic Counseling, and Genetic Testing for BRCA-Related Cancer: Systematic Review to Update the U.S. Preventive Services Task Force Recommendation. Evidence Synthesis No. 101. AHRQ Publication No. 12-05164-EF-1 2013, Rockville, MD, Agency for Healthcare Research and Quality.
38. Teller P, Hoskins KF, Zwaagstra A, Stanislaw C, Iyengar R, Green VL, Gabram SG. Validation of the pedigree assessment tool (PAT) in families with BRCA1 and BRCA2 mutations. Ann Surg Oncol 2010, 17:240-246. 10.1245/s10434-009-0697-9, 19763692.
39. Sonka M, Hlavac V, Boyle R. Image Processing, Analysis, and Machine Vision 1999, Pacific Grove, CA, Brooks/Cole.
40. Chen W, Giger ML, Li H, Bick U, Newstead GM. Volumetric texture analysis of breast lesions on contrast-enhanced magnetic resonance images. Magn Reson Med 2007, 58:562-571. 10.1002/mrm.21347, 17763361.
41. Haralick RM, Shanmugan K, Dinstein I. Textural features for image classification. IEEE Trans Syst Man Cybern 1973, 6:610-621. 10.1109/TSMC.1973.4309314.
42. Huberty CJ. Applied Discriminant Analysis 1994, John Wiley and Sons, Inc., New York, NY.
43. Lachenbruch PA. Discriminant Analysis 1975, Hafner, New York.
44. Metz CE. Some practical issues of experimental design and data analysis in radiological ROC studies. Invest Radiol 1989, 24:234-245. 10.1097/00004424-198903000-00012, 2753640.
45. Metz CE, Herman BA, Shen JH. Maximum likelihood estimation of receiver operating characteristic (ROC) curves from continuously-distributed data. Stat Med 1998, 17:1033-1053. 10.1002/(SICI)1097-0258(19980515)17:9<1033::AID-SIM784>3.0.CO;2-Z, 9612889.
46. ROCKIT, version 1.1b. []., http://metz-roc.uchicago.edu/MetzROC/software
47. Metz CE, Herman BA, Roe CA. Statistical comparison of two ROC-curve estimates obtained from partially-paired datasets. Med Decis Making 1998, 18:110-121. 10.1177/0272989X9801800118, 9456215.
48. Li H, Giger ML, Lan L, Yuan Y, Bhooshan N, Olopade O. Effect of variable gain on computerized texture analysis on digitized mammograms. Proc SPIE Med Imag Conf 2010, 7624:76242C1-76242C6. 10.1117/12.844370.
49. Li H, Giger ML, Lan L, Bancroft Brown J, MacMahon A, Mussman M, Olopade OI, Sennett C. Computerized analysis of mammographic parenchymal patterns on a large clinical dataset of full-field digital mammograms: robustness study with two high-risk datasets. J Digit Imaging 2012, 25:591-598. 10.1007/s10278-012-9452-z, 22246204.
50. Pisano ED, Gatsonis C, Hendrick E, Yaffe M, Baum JK, Acharyya S, Conant EF, Fajardo LL, Bassett L, D'Orsi C, Jong R, Rebner M. Digital Mammographic Imaging Screening Trial Investigators Group: Diagnostic performance of digital versus film mammography for breast-cancer screening. N Engl J Med 2005, 353:1773-1783. 10.1056/NEJMoa052911, 16169887.
51. Cummings SR, Tice JA, Bauer S, Browner WS, Cuzick J, Ziv E, Vogel V, Shepherd J, Vachon C, Smith-Bindman R, Kerlikowske K. Prevention of breast cancer in postmenopausal women: approaches to estimating and reducing risk. J Natl Cancer Inst 2009, 101:384-398. 10.1093/jnci/djp018, 19276457.
52. Martin LJ, Boyd NF. Mammographic density - Potential mechanisms of breast cancer risk associated with mammographic density: hypotheses based on epidemiological evidence. Breast Cancer Res 2008, 10:201. 10.1186/bcr1831, 18226174.
53. Sun X, Gierach GL, Sandhu R, Williams T, Midkiff BR, Lissowska J, Wesolowska E, Boyd NF, Johnson NB, Figueroa JD, Sherman ME, Troester MA. Relationship of mammographic density and gene expression: analysis of normal breast tissue surrounding breast cancer. Clin Cancer Res 2013, 19:4972-4982. 10.1158/1078-0432.CCR-13-0029, 23918601.
54. Lim E, Vaillant F, Wu D, Forrest NC, Pal B, Hart AH, Asselin-Labat ML, Gyorki DE, Ward T, Partanen A, Feleppa F, Huschtscha LI, Thorne HJ, kConFab, Fox SB, Yan M, French JD, Brown MA, Smyth GK, Visvader JE, Lindeman GJ. Aberrant luminal progenitors as the candidate target population for basal tumor development in BRCA1 mutation carriers. Nat Med 2009, 15:907-913. 10.1038/nm.2000, 19648928.
55. Mavaddat N, Barrowdale D, Andrulis IL, Domchek SM, Eccles D, Nevanlinna H, Ramus SJ, Spurdle A, Robson M, Sherman M, Mulligan AM, Couch FJ, Engel C, McGuffog L, Healey S, Sinilnikova OM, Southey MC, Terry MB, Goldgar D, O'Malley F, John EM, Janavicius R, Tihomirova L, Hansen TV, Nielsen FC, Osorio A, Stavropoulou A, Benitez J, Manoukian S, Peissel B, et al. Pathology of breast and ovarian cancers among BRCA1 and BRCA2 mutation carriers: results from the Consortium of Investigators of Modifiers of BRCA1/2 (CIMBA). Cancer Epidemiol Biomarkers Prev 2012, 21:134-147. 10.1158/1055-9965.EPI-11-0775, 22144499.
56. Silver DP, Livingston DM. Mechanisms of BRCA1 tumor suppression. Cancer Discovery 2012, 2:679-684. 10.1158/2159-8290.CD-12-0221, 22843421.
57. Roy R, Chun J, Powell SN. BRCA1 and BRCA2: different roles in a common pathway of genome protection. Nat Rev Cancer 2012, 12:68-78. 10.1038/nrc3181.
58. Antoniou AC, Hardy R, Walker L, Evans DG, Shenton A, Eeles R, Shanley S, Pichert G, Izatt L, Rose S, Douglas F, Eccles D, Morrison PJ, Scott J, Zimmern RL, Easton DF, Pharoah PD. Predicting the likelihood of carrying a BRCA1 or BRCA2 mutation: validation of BOADICEA, BRCAPRO, IBIS, Myriad and the Manchester scoring system using data from UK genetics clinics. J Med Genet 2008, 45:425-431. 10.1136/jmg.2007.056556, 18413374.